Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107025625 | 10702562 | 5 | F | 201005 | 20160324 | 20150109 | 20160331 | EXP | US-PFIZER INC-2015005340 | PFIZER | 65.00 | YR | F | Y | 90.72000 | KG | 20160331 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107025625 | 10702562 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 2X/DAY | A440301 | 21845 | 20 | MG | FILM-COATED TABLET | BID | |||||
| 107025625 | 10702562 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 107025625 | 10702562 | 3 | SS | LETAIRIS | AMBRISENTAN | 1 | UNK | 0 | |||||||||||
| 107025625 | 10702562 | 4 | C | BUMETANIDE. | BUMETANIDE | 1 | 2 MG, 2X/DAY | 0 | 2 | MG | BID | ||||||||
| 107025625 | 10702562 | 5 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 10 MG, AS NEEDED | 0 | 10 | MG | |||||||||
| 107025625 | 10702562 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 137 ^MG^, DAILY | 0 | 137 | MG | |||||||||
| 107025625 | 10702562 | 7 | C | ESTAZOLAM. | ESTAZOLAM | 1 | 2 MG, (AT BED TIME) AS NEEDED | 0 | 2 | MG | |||||||||
| 107025625 | 10702562 | 8 | C | ESTAZOLAM. | ESTAZOLAM | 1 | 0 | ||||||||||||
| 107025625 | 10702562 | 9 | C | METOLAZONE. | METOLAZONE | 1 | 2.5 MG, ONE TO TWO DAYS AS NEEDED | 0 | 2.5 | MG | |||||||||
| 107025625 | 10702562 | 10 | C | MELATONIN | MELATONIN | 1 | UNK | 0 | |||||||||||
| 107025625 | 10702562 | 11 | C | DILTIAZEM | DILTIAZEM | 1 | 30 MG, 2X/DAY | 0 | 30 | MG | BID | ||||||||
| 107025625 | 10702562 | 12 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | QD | ||||||||
| 107025625 | 10702562 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 107025625 | 10702562 | 14 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, AS NEEDED | 0 | 50 | MG | |||||||||
| 107025625 | 10702562 | 15 | C | IBANDRONATE SODIUM. | IBANDRONATE SODIUM | 1 | 150 MG, MONTHLY | 0 | 150 | MG | TABLET | /month | |||||||
| 107025625 | 10702562 | 16 | C | COUMADIN | WARFARIN SODIUM | 1 | 5 MG, 5 DAYS A WEEK | 0 | 5 | MG | |||||||||
| 107025625 | 10702562 | 17 | C | COUMADIN | WARFARIN SODIUM | 1 | 7.5 MG OTHER 2 DAYS OF THE WEEK | 0 | 7.5 | MG | |||||||||
| 107025625 | 10702562 | 18 | C | LANTUS | INSULIN GLARGINE | 1 | 5 UNITS, UNK | 0 | |||||||||||
| 107025625 | 10702562 | 19 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 50 ?G, UNK | 0 | 50 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107025625 | 10702562 | 1 | Pulmonary hypertension |
| 107025625 | 10702562 | 6 | Thyroid disorder |
| 107025625 | 10702562 | 7 | Sleep disorder |
| 107025625 | 10702562 | 8 | Parasomnia |
| 107025625 | 10702562 | 9 | Swelling |
| 107025625 | 10702562 | 16 | Implantable defibrillator insertion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107025625 | 10702562 | HO |
| 107025625 | 10702562 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107025625 | 10702562 | Drug dose omission | |
| 107025625 | 10702562 | Feeling abnormal | |
| 107025625 | 10702562 | Fluid retention | |
| 107025625 | 10702562 | Photopsia | |
| 107025625 | 10702562 | Pulmonary arterial pressure decreased | |
| 107025625 | 10702562 | Swelling | |
| 107025625 | 10702562 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107025625 | 10702562 | 1 | 201004 | 0 | ||
| 107025625 | 10702562 | 2 | 201005 | 0 | ||
| 107025625 | 10702562 | 4 | 201012 | 0 | ||
| 107025625 | 10702562 | 5 | 2011 | 0 | ||
| 107025625 | 10702562 | 6 | 1994 | 0 | ||
| 107025625 | 10702562 | 7 | 1991 | 0 | ||
| 107025625 | 10702562 | 9 | 2010 | 0 | ||
| 107025625 | 10702562 | 10 | 1998 | 0 | ||
| 107025625 | 10702562 | 11 | 2013 | 0 | ||
| 107025625 | 10702562 | 12 | 2010 | 0 | ||
| 107025625 | 10702562 | 13 | 2010 | 0 | ||
| 107025625 | 10702562 | 14 | 2014 | 0 | ||
| 107025625 | 10702562 | 15 | 201409 | 0 | ||
| 107025625 | 10702562 | 16 | 199510 | 0 | ||
| 107025625 | 10702562 | 18 | 199510 | 0 | ||
| 107025625 | 10702562 | 19 | 2000 | 0 |